"The Report Global
Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size,
Trends & Forecasts (2016-2020) provides information on pricing,
market analysis, shares, forecast, and company profiles for key
industry participants. - MarketResearchReports.biz"
Scope of the Report
The
report titled Global Chemotherapy Induced Nausea & Vomiting
(CINV) Market: Size, Trends & Forecasts (2016-2020), provides and
in-depth analysis of the global CINV market and respective drugs. The
report gives an insight of the global CINV market by 5-HT3 and NK-1
drug receptor antagonists.
The
report also includes the analysis of North American CINV market. The
report also assesses the key opportunities in the market and outlines
the factors that are and will be driving the growth of the industry.
Growth of the overall global CINV market has also been forecasted for
the period 2016-2020, taking into consideration the previous growth
patterns, the growth drivers and the current and future trends.
View Report @
http://www.marketresearchreports.biz/analysis/841067
The
competition in global CINV market is fragmented as the specific
treatment for CINV is still at a nascent stage with several drugs by
multiple competitors already thriving the market and some are under
formulation.
The
key players of the global CINV market, Heron Therapeutics, Inc.,
Merck & Co., Inc., Novartis AG and TESARO, Inc. are also profiled
with their financial information and respective business strategies
Country Coverage
North
America
Company Coverage
Heron
Therapeutics, Inc.
Merck
& Co., Inc.
Novartis
AG
TESARO,
Inc.
Get Sample Copy Of This Report
@
Executive Summary
Chemotherapy
induced nausea and vomiting (CINV) is the most dreaded side-effect of
chemotherapy among the cancer patients. Therefore, sometimes patients
either do not undergo the chemotherapy or discontinue in the prior
year of treatment. CINV is also of various types such as acute,
breakthrough, delayed, anticipatory and refractory. HEC and MEC
regimens cause the CINV. Several treatments of CINV are on the verge
of emergence such as 5-HT3 receptor antagonist, NK-1 blocker,
corticosteroids, cannabinoids and dopamine antagonists. However,
there are several unmet medical needs in the field of HEC regimen of
delayed CINV.
Global
CINV market has increased at a significant CAGR during the years
2013-2015 and projections are made that the market would rise
tremendously in the next four years i.e. 2016-2020. The CINV market
is expected to increase due to growth in global cancer incidence,
increasing health expenditure and the increasing outbreak of factors
working towards causing cancer. Yet, the market faces some challenges
such as discontinuation of chemotherapy treatment, several unmet
medical needs, no drugs for the HEC regimen in the delayed CINV, etc.
Table Of Contents :
1.
Executive Summary
2.
Introduction
2.1
Chemotherapy: An Overview
2.1.1
Side-Effects of Chemotherapy
2.1.2
Delivery Methods of Chemotherapy
2.1.3
Types of Chemotherapy Drugs
2.1.4
Pros & Cons of Chemotherapy
2.2
CINV: An Overview
2.2.1
Types of CINV
2.2.2
CINV Mechanism
2.2.3
Regimens Causing CINV
2.2.4
Treatment/Prevention of CINV
3.
Global Market Analysis
3.1
Global CINV Market: An Analysis
3.1.1
Global CINV Market Opportunity
3.1.2
Global CINV Market by Value
3.2
Global NK-1 Drug Receptor Antagonist Market
3.2.1
Global VARUBI Sales
3.2.2
Global Emend (Injectable) Sales
3.3
Global 5-HT3 Drug Receptor Antagonist Market
3.3.1
Global Aloxi (Injectable) Sales
3.3.2
Global Granisetron (Injectable) & Ondansetron (Injectable) Sales
4.
Regional Market Analysis
4.1
North America CINV Market: An Analysis
4.1.1
North America CINV Market by Value
4.1.2
US CINV Market Opportunity
4.1.3
US CINV Market by Drugs Prescription
5.
Market Dynamics
5.1
Growth Driver
5.1.1
Rising Global Incidence of Cancer
5.1.2
Widening Causes of Cancer
5.1.3
Rising Global Healthcare Expenditure
5.2
Challenges
5.2.1
No Drug for Delayed CINV- HEC Regimens
5.2.2
Unmet Medical Needs
5.2.3
Discontinuation of Chemotherapy Treatment
5.2.4
Under-Utilized Antagonists
5.3
Market Trends
5.3.1
Breakthrough CINV
5.3.2
Side-Effects of Chemotherapy
5.3.3
Need for Inclusion of NK1 Blocker
5.3.4
Availability of Generic Products
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment